Affluent Medical SA (AFME.PA)
EUR 1.54
(0.99%)
EUR 1.54
(0.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 1.22 Million | 1.33 Million | 1.45 Million | 824 Thousand | 1.42 Million | 43 Thousand |
| Cost of Revenue | 2.42 Million | 2.44 Million | 2.51 Million | 3.1 Million | 2.26 Million | 5.99 Million |
| Gross Profit | -1.2 Million | -1.1 Million | -1.06 Million | -2.28 Million | -831 Thousand | -5.95 Million |
| Operating Expenses | 11.86 Million | 11.82 Million | 10.73 Million | 9.48 Million | 13.02 Million | 4.4 Million |
| Selling, General and Administrative Expenses | 11.86 Million | 5.24 Million | 5.2 Million | 3.35 Million | 12.99 Million | 2.42 Million |
| Research and Development Expenses | - | 52 Thousand | 23 Thousand | 9000.00 | - | - |
| Other Expenses | - | 6.57 Million | 5.52 Million | 6.13 Million | -34 Thousand | 1.97 Million |
| Cost and Expenses | 14.29 Million | 14.26 Million | 13.25 Million | 12.59 Million | 15.28 Million | 10.4 Million |
| Operating Income | -13.06 Million | -14.29 Million | -13.23 Million | -12.59 Million | -15.28 Million | -10.29 Million |
| Interest Expense | 393 Thousand | 1.08 Million | 3.05 Million | 2.16 Million | 1.88 Million | 166 Thousand |
| Income Tax Expense | 150 Thousand | -173 Thousand | -437 Thousand | -209 Thousand | -1.29 Million | -1.66 Million |
| Earnings before Tax | -15.8 Million | -15.4 Million | -15.25 Million | -14.52 Million | -16.69 Million | -10.42 Million |
| Net Income | -15.65 Million | -15.22 Million | -14.82 Million | -14.31 Million | -16.58 Million | -8.75 Million |
| Earnings Per Share Basic | -0.54 | -0.81 | -0.80 | -0.77 | -0.89 | -0.74 |
| Earnings Per Share Diluted | -0.54 | -0.81 | -0.80 | -0.77 | -0.89 | -0.72 |
| Weighted Average Shares Outstanding | 28.98 Million | 18.88 Million | 18.59 Million | 18.59 Million | 18.59 Million | 11.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.09 Million | 18.88 Million | 18.59 Million | 18.59 Million | 18.59 Million | 12.18 Million |
| Gross Margin | -0.98 | -0.82 | -0.74 | -2.77 | -0.58 | -138.44 |
| EBIT Margin | -10.90 | -8.81 | -7.47 | -12.74 | -9.11 | -232.37 |
| Profit Margin | -12.79 | -11.37 | -10.21 | -17.38 | -11.61 | -203.53 |
| EBITDA | -13.34 Million | -12.33 Million | -10.88 Million | -10.47 Million | -12.55 Million | -9.96 Million |
| Earnings Before Tax Margin | -10.67 | -10.67 | -9.12 | -15.28 | -10.70 | -239.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 330.5 Thousand | 330.5 Thousand | 317 Thousand | 1.22 Million | 317 Thousand | 295 Thousand |
| Cost of Revenue | 459 Thousand | 459 Thousand | 623.5 Thousand | 2.41 Million | 477.5 Thousand | 1.2 Million |
| Gross Profit | -128.5 Thousand | -128.5 Thousand | -306.5 Thousand | -1.18 Million | -160.5 Thousand | -911 Thousand |
| Operating Expenses | 4.27 Million | 4.27 Million | 3.7 Million | 14.38 Million | 3.85 Million | 6.91 Million |
| Selling, General and Administrative Expenses | 3.7 Million | 3.7 Million | 3.09 Million | - | 3.23 Million | 6.86 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 569 Thousand | 569 Thousand | -48 Thousand | -97 Thousand | - | -49 Thousand |
| Cost and Expenses | 4.73 Million | 4.73 Million | 4.33 Million | 16.8 Million | 4.32 Million | 8.11 Million |
| Operating Income | -4.4 Million | -4.4 Million | -3.98 Million | -16.8 Million | -3.98 Million | -8.11 Million |
| Interest Expense | 739 Thousand | - | - | 393 Thousand | - | 686 Thousand |
| Income Tax Expense | 38.5 Thousand | 38.5 Thousand | 36 Thousand | -1.35 Million | 36 Thousand | -660 Thousand |
| Earnings before Tax | -4.72 Million | -4.72 Million | -3.87 Million | -17.01 Million | -3.87 Million | -8.64 Million |
| Net Income | -4.68 Million | -4.68 Million | -3.83 Million | -15.65 Million | -3.83 Million | -7.98 Million |
| Earnings Per Share Basic | -0.14 | -0.15 | -0.13 | - | -0.13 | -0.29 |
| Earnings Per Share Diluted | -0.14 | -0.15 | -0.12 | - | -0.13 | -0.29 |
| Weighted Average Shares Outstanding | 32.78 Million | 31.59 Million | 30.4 Million | 29.09 Million | 28.93 Million | 27.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.78 Million | 31.85 Million | 30.92 Million | 29.09 Million | 28.93 Million | 27.25 Million |
| Gross Margin | -0.39 | -0.39 | -0.97 | -0.97 | -0.51 | -3.09 |
| EBIT Margin | -11.51 | -11.51 | -10.95 | - | -10.39 | -23.42 |
| Profit Margin | -14.17 | -14.17 | -12.10 | -12.79 | -12.10 | -27.05 |
| EBITDA | -3.8 Million | -3.8 Million | -3.47 Million | - | -3.29 Million | -6.91 Million |
| Earnings Before Tax Margin | -13.32 | -13.32 | -12.58 | -13.73 | -12.58 | -27.51 |
SHCAY
9082
KACL
HLEGLAS
002020
2669